Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
Recruiting · NCT06763081 · Registry updated 2025-09-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, anxiety disorder, depressive disorder, major depressive disorder, mood disorder, obsessive-compulsive disorder, psychiatric disorder | Recruiting | Not stated | 2025-09-08 | NCT06763081 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Children's Hospital Research Institute of Manitoba | 7 |
| Health Sciences Centre Foundation, Manitoba | 3 |
| University of Calgary | 238 |
| University of Manitoba | 110 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shared Health Facilities | Winnipeg | Canada | 2 |
| University of Manitoba College of Pharmacy | Winnipeg | Canada | 2 |